Carbohydrate Strengthens the Immunotherapeutic Effect of Small-Molecule PD-L1 Inhibitors
Journal of Medicinal Chemistry · 08.06.2023 · 66 (11) · 7179-7204
DOI: 10.1021/acs.jmedchem.2c01347 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 25.05.2023. Verfasst von Qian Dong und 15 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Science and Technology, Hangzhou Institute of Advanced Study, Hangzhou 310024, China. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, T-Lymphocytes. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Science and Technology Commission of Shanghai Municipality, National Natural Science Foundation of China, Hangzhou innovation and entrepreneurship leading team project.
Abstract (Originalsprache)
PD-1/PD-L1 checkpoint blockade has demonstrated great success in cancer immunotherapy. Small-molecule PD-L1 inhibitors also attract significant research interests but remain challenging in the efficacy and safety. Carbohydrate moiety and carbohydrate-binding proteins (lectins) play important roles in immune modulation including antigen recognition and presenting. Herein, we reported a novel strategy to strengthen the immunotherapeutic effect of small-molecule PD-L1 inhibitors by introducing sugar motifs, which may utilize the carbohydrate-mediated immune enhancement for cancer treatment. The data revealed that glycoside compounds containing mannose or N-acetylglucosamine exhibited the best results in IFN-γ secretion. Moreover, compared to the nonglycosylated compounds, glycosides C3 and C15 demonstrated significant lower cytotoxicity and effective in vivo antitumor potency in the CT26 and melanoma B16-F10 tumor models with good tolerance. Notably, tumor-infiltrating lymphocyte (TIL) analysis validated increased CD3+, CD4+, CD8+, and granzyme B+ T cells after glycoside treatments. This work presents a new concept to improve the immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Science and Technology, Hangzhou Institute of Advanced Study, Hangzhou 310024, China.
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
- University of Chinese Academy of Sciences, Beijing 100049, China.
ORCID-Profile: Dongliang Guan, Hu Zhou, Yongzhuo Huang, Wei Huang
Förderung
- Science and Technology Commission of Shanghai Municipality
- National Natural Science Foundation of China
- Hangzhou innovation and entrepreneurship leading team project
Zitieren
APA
Dong, Q., Tong, M., Yu, X., Wang, L., Ao, J., Guan, D., Tang, Y., Liu, J., Long, L., Tong, Y., Fang, S., Zhou, H., Huang, Y., Gong, L., Lou, L., & Huang, W. (2023). Carbohydrate Strengthens the Immunotherapeutic Effect of Small-Molecule PD-L1 Inhibitors. Journal of Medicinal Chemistry, 66(11), 7179-7204. https://doi.org/10.1021/acs.jmedchem.2c01347
Vancouver
Dong Q, Tong M, Yu X, Wang L, Ao J, Guan D, et al. Carbohydrate Strengthens the Immunotherapeutic Effect of Small-Molecule PD-L1 Inhibitors. Journal of Medicinal Chemistry. 2023;66(11):7179-7204. doi:10.1021/acs.jmedchem.2c01347
BibTeX
@article{Dong2023,
author = {Dong, Qian and Tong, Mengya and Yu, Xiaolu and Wang, Lei and Ao, Jiwei and Guan, Dongliang and Tang, Yubo and Liu, Junjie and Long, Li and Tong, Yongliang and Fang, Shanhua and Zhou, Hu and Huang, Yongzhuo and Gong, Likun and Lou, Liguang and Huang, Wei},
title = {Carbohydrate Strengthens the Immunotherapeutic Effect of Small-Molecule PD-L1 Inhibitors},
journal = {Journal of Medicinal Chemistry},
year = {2023},
volume = {66},
number = {11},
pages = {7179--7204},
doi = {10.1021/acs.jmedchem.2c01347}
}
EUVIMED